StockData

Orchestra BioMed Holdings, Inc. (OBIO) stock

OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$7.12−0.13 (-1.79%)

Close on Nov 16, 2026Market cap $427.95MP/E –Yield –

Orchestra BioMed total assets

Total assets on the balance sheet at the end of each period.

Orchestra BioMed's total assets was $115.70M at Jun 30, 2026. For fiscal 2025 it was $114.86M, up 50.8% from the year before. The highest annual figure on record is $162.16M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$114.86M+50.8%
FY2024Dec 31, 2024$76.17M-20.0%
FY2023Dec 31, 2023$95.21M-0.4%
FY2022Dec 31, 2022$95.57M-40.9%
FY2021Dec 31, 2021$161.82M-0.2%
FY2020Dec 31, 2020$162.16M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$115.70M+170.2%
Q1 FY2026Mar 31, 2026$100.66M+70.5%
Q4 FY2025Dec 31, 2025$114.86M+50.8%
Q3 FY2025Sep 30, 2025$104.81M+39.2%
Q2 FY2025Jun 30, 2025$42.83M-40.8%
Q1 FY2025Mar 31, 2025$59.05M-28.5%
Q4 FY2024Dec 31, 2024$76.17M-20.0%
Q3 FY2024Sep 30, 2024$75.32M-35.3%
Q2 FY2024Jun 30, 2024$72.38M-42.5%
Q1 FY2024Mar 31, 2024$82.63M-39.4%
Q4 FY2023Dec 31, 2023$95.21M-0.4%
Q3 FY2023Sep 30, 2023$116.36M+69.5%
Q2 FY2023Jun 30, 2023$125.88M-22.1%
Q1 FY2023Mar 31, 2023$136.28M-15.6%
Q4 FY2022Dec 31, 2022$95.57M-40.9%
Q3 FY2022Sep 30, 2022$68.65M-57.6%
Q2 FY2022Jun 30, 2022$161.58M-0.3%
Q1 FY2022Mar 31, 2022$161.53M-0.4%
Q4 FY2021Dec 31, 2021$161.82M-0.2%
Q3 FY2021Sep 30, 2021$161.88M-0.2%
Q2 FY2021Jun 30, 2021$162.03M–
Q1 FY2021Mar 31, 2021$162.10M–
Q4 FY2020Dec 31, 2020$162.16M–
Q3 FY2020Sep 30, 2020$162.20M–

More Orchestra BioMed figures

See a number that looks wrong?